Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vyripharm
Houston, Texas, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Vyripharm is developing a novel theranostic platform integrating diagnostics and therapeutics with data analytics and artificial intelligence for personalized medicine. The company is in preclinical stage with multiple programs targeting neurological disorders, infectious diseases, and oncology.[1][2][3]
- Therapeutic areas
- PsychiatryInfectious DiseasesNeurologyOncology
- Modalities
- Small moleculeRadiopharmaceutical
- Industry
- Biotech
02
Partnerships
National Yang-Ming UniversityABB RoboticsRegis Technologies Inc.Ward Medication Management
Beyond the preview
Go deeper on Vyripharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vyripharm.